Lionsgate and Universal’s $200 million Michael Jackson biopic “Michael” opens this weekend despite a Rotten Tomatoes score of 39%, having undergone $15 million in reshoots after legal threats from the estate’s settlement with Jordan Chandler forced the scrapping of its entire third act just months before release, turning a planned deep dive into Jackson’s 2005 trial into a truncated origin story ending on the triumph of the “Bad” tour, with sequel potential already being discussed if the film crosses $700 million worldwide.
The Bottom Line
- The film’s troubled production highlights how celebrity estates now wield veto power over biopic narratives, turning artistic projects into brand extensions.
- Despite poor reviews, “Michael” is projected for a $90–110 million domestic opening, testing whether nostalgia-driven IP can overcome critical rejection in today’s fragmented theatrical market.
- The film’s open-ended conclusion and sequel talks reflect a broader Hollywood shift toward franchise-building from legacy music IP, even when core controversies are legally off-limits.
How a Settlement Clause Sank the Third Act—and What It Says About Estate Control in Hollywood
When Lionsgate greenlit “Michael” in 2019, the pitch was simple: combine the awards prestige of “Bohemian Rhapsody” with the catalog power of Jackson’s master recordings, which Sony Music valued at $1.5 billion in its 2024 deal for half the publishing rights. But the estate’s involvement proved a double-edged sword. As producer Graham King told The Recent Yorker in March, “We went in wanting to tell the full story—the man, the myth, the moonwalking legend—but the second we stepped into legal territory, the estate handed us a red pen.” That red pen came in the form of a 1994 settlement clause with Jordan Chandler, the first accuser whose allegations led to a $23 million payout, which explicitly barred any depiction of Chandler in film, television, or stage productions. The clause wasn’t discovered until after principal photography wrapped in April 2024, forcing Fuqua, Logan, and Lionsgate to jettison not just the trial sequence but the entire third act, which had been built around Jackson’s legal vindication and emotional aftermath. The resulting $15 million in reshoots—paid for by the estate, which then took an equity stake—shifted the film’s focus from accountability to ascension, ending on a title card with ellipses that explicitly tease a sequel. As one anonymous producer told TheWrap, “They made a creative decision to complete before the stuff they’re not allowed to use. It definitely causes a perception issue in the marketplace.”
Why Studios Are Betting on Troubled Legacies—And What It Means for the Streaming Wars
“Michael” arrives at a pivotal moment in Hollywood’s franchise economics. With streaming growth slowing and subscriber churn rising—Netflix lost 970,000 subscribers in Q2 2023 before rebounding, while Disney+ still trails Netflix by 40 million domestic users—studios are doubling down on proven IP that can drive theatrical urgency and post-theatrical longevity. Jackson’s catalog is uniquely positioned: his estate has earned over $3.5 billion since his death in 2009, and “MJ the Musical” has grossed more than $300 million on Broadway since 2021, proving there’s still monetizable demand for his story. But unlike biopics about Freddie Mercury or Elton John, Jackson’s narrative is legally constrained. As media analyst Julia Alexander of Parrot Analytics told me in an exclusive interview, “What Lionsgate and Universal are really selling isn’t a biopic—it’s a delivery system for the Jackson catalog. Every frame of ‘Michael’ is designed to reignite interest in the master recordings, which now generate an estimated $150–200 million annually in streaming royalties alone.” That explains why Sony Music is releasing the soundtrack despite backing away from distribution: the real profit engine isn’t the box office—it’s the algorithmic bump in Spotify and Apple Music streams that follows a major biopic release. In the weeks after “Bohemian Rhapsody” premiered, Queen’s global streams increased by 220%; similar spikes followed “Elvis” and “Rocketman.” For studios, the theatrical release is now often just the top of a monetization funnel.
The Sequel Gambit: How “Michael” Could Launch a Franchise Without Touching the Controversy
Lionsgate’s post-release strategy for “Michael” mirrors its approach to the “John Wick” universe: build a modular IP ecosystem where sequels can explore different eras or themes without requiring narrative continuity. Colman Domingo’s hint on “Today” about a potential Part 2 focusing on Jackson’s “love of animals” isn’t whimsy—it’s a calculated pivot to safer, more brand-friendly territory. The estate has long leveraged Jackson’s affection for chimpanzees (Bubbles) and exotic animals at Neverland as wholesome counterprogramming to the abuse allegations, even featuring them in the 1993 “Jam” video. A sequel could explore Jackson’s philanthropy, his pet chimpanzee, or his unrealized plans for a Neverland-themed children’s hospital—all legally unencumbered and emotionally resonant. As film financier Jason Squire, professor at USC’s School of Cinematic Arts, explained in a recent Bloomberg interview, “Studios aren’t just making sequels anymore—they’re making IP platforms. With ‘Michael,’ Lionsgate has a chance to create a ‘Star Wars’-style anthology where each film explores a different facet of Jackson’s legacy: his artistry, his philanthropy, his fandom—all while avoiding the legal minefields.” This approach could redefine how studios handle troubled legacies: not by confronting them head-on, but by building parallel narratives that keep the IP alive and profitable.
| Metric | Value | Source |
|---|---|---|
| Production Budget | $200 million | Variety |
| Reshoot Cost | $15 million | Deadline |
| Projected Domestic Opening | $90–110 million | The Hollywood Reporter |
| Jackson Estate Value (2024) | $2 billion | Bloomberg |
| Annual Music Royalties (Est.) | $150–200 million | Billboard |
The Cultural Tightrope: Nostalgia, Accountability, and the Future of Legacy Biopics
What makes “Michael” particularly revealing is how it exposes the tension between nostalgia-driven storytelling and cultural accountability. The film’s decision to end before the 2005 trial—despite early promises to tackle the allegations head-on—mirrors a broader industry trend where studios prioritize IP safety over narrative completeness. As cultural critic Wesley Morris noted in a recent New York Times essay, “We’re entering an era where the biopic isn’t about truth—it’s about tribute. And tribute, by its nature, avoids the uncomfortable.” That tension is palpable in audience reactions: while older fans praise the film for celebrating Jackson’s artistry, younger viewers on TikTok and Twitter have criticized its omission of the allegations as a form of historical erasure, with the hashtag #MichaelJacksonDeservedBetter trending briefly after early screenings. Yet the estate’s legal posture remains unyielding. As Taj Jackson told X this week, “Sorry media, u don’t get to control the narrative anymore of who Michael Jackson truly was.” That stance reflects a new power dynamic in Hollywood: estates aren’t just consultants—they’re co-financiers, co-owners, and the final arbiters of what gets shown on screen. For better or worse, “Michael” isn’t just a movie about the King of Pop—it’s a case study in who gets to tell the story when the legend becomes too valuable to risk.
As “Michael” hits theaters this weekend, its real box office may not be measured in ticket sales alone, but in how it reshapes the rules for legacy biopics in an era where IP is king, estates are kingmakers, and the line between tribute and revisionism has never been thinner. What do you think—can a biopic be both commercially successful and culturally honest when its subject’s legacy is legally contested? Drop your thoughts below; I’ll be reading and responding to the most thoughtful takes.
